{
    "eid": "2-s2.0-85125851817",
    "title": "A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial",
    "cover-date": "2022-04-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hepatology",
            "@code": "2721",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Gastroenterology",
            "@code": "2715",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "Sunil S. Solomon",
        "Sandra Wagner-Cardoso",
        "Laura Smeaton",
        "Leonard A. Sowah",
        "Chanelle Wimbish",
        "Gregory Robbins",
        "Irena Brates",
        "Christine Scello",
        "Annie Son",
        "Anchalee Avihingsanon",
        "Benjamin Linas",
        "Donald Anthony",
        "Estev\u00e3o Portela Nunes",
        "Dimas A. Kliemann",
        "Khuanchai Supparatpinyo",
        "Cissy Kityo",
        "Pablo Tebas",
        "Jaclyn Ann Bennet",
        "Jorge Santana-Bagur",
        "Constance A. Benson",
        "Marije Van Schalkwyk",
        "Nelson Cheinquer",
        "Susanna Naggie",
        "David Wyles",
        "Mark Sulkowski"
    ],
    "citedby-count": 23,
    "ref-count": 33,
    "ref-list": [
        "Global elimination of chronic hepatitis",
        "Interim guidance for country validation of viral hepatitis elimination",
        "Progress towards hepatitis C virus elimination in high-income countries: an updated analysis",
        "A guide to the economics of hepatitis C virus cure in 2017",
        "Accelerating access to hepatitis C diagnostics and treatment. Overcoming barriers in low and middle-income countries. Global progress report 2020",
        "Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study",
        "Cost-effectiveness and budgetary impact of HCV treatment with direct-acting antivirals in India including the risk of reinfection",
        "Impact of COVID-19 on global HCV elimination efforts",
        "Hepatitis C guidance 2019 update: American Association for the Study of Liver Diseases\u2013Infectious Diseases Society of America recommendations for testing, managing, and treating hepatitis C virus infection",
        "EASL recommendations on treatment of hepatitis C: final update of the series",
        "Minimal compared with standard monitoring during sofosbuvir-based hepatitis C treatment: a randomized controlled trial",
        "Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trial",
        "Sofosbuvir-velpatasvir single-tablet regimen administered for 12 weeks in a phase 3 study with minimal monitoring in India",
        "Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection",
        "BLAST\u00ae Basic Local Alignment Search Tool",
        "Division of AIDS (DAIDS) table for grading the severity of adult and pediatric adverse events. corrected version 2.1, July 2017",
        "Validation of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST)",
        "The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST). Manual for use in primary care",
        "Sofosbuvir and velpatasvir for HCV genotype 2 and 3 infection",
        "Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection",
        "Global real-world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: analysis of 5552 patients from 12 cohorts",
        "Real-world effectiveness of sofosbuvir/velpatasvir for treatment of chronic hepatitis C in British Columbia, Canada: a population-based cohort study",
        "Risk assessment and screening for sexually transmitted infections, HIV, and hepatitis virus among long-distance truck drivers in New Mexico, 2004-2006",
        "Black box warning for possible HBV reactivation during DAA therapy for chronic HCV infection",
        "Hepatitis B virus reactivation associated with direct-acting antiviral therapy for chronic hepatitis C virus: a review of cases reported to the U.S. Food and Drug Administration adverse event reporting system",
        "Sofosbuvir and velpatasvir for the treatment of hepatitis C virus in patients coinfected with human immunodeficiency virus type 1: an open-label, phase 3 study",
        "Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review",
        "Resistance analysis of genotype 3 hepatitis C virus indicates subtypes inherently resistant to nonstructural protein 5A inhibitors",
        "Real-world effectiveness of daclatasvir plus sofosbuvir and velpatasvir/sofosbuvir in hepatitis C genotype 2 and 3",
        "Evaluation of the Xpert HCV Viral Load point-of-care assay from venipuncture-collected and finger-stick capillary whole-blood samples: a cohort study",
        "Hepatitis C core antigen testing for diagnosis of hepatitis C virus infection: a systematic review and meta-analysis",
        "Decentralised hepatitis C testing and treatment in rural Cambodia: evaluation of a simplified service model integrated in an existing public health system",
        "A same day \u2018test and treat\u2019 model for chronic HCV and HBV infection: results from two community-based pilot studies in Egypt"
    ],
    "affiliation": [
        {
            "affiliation-city": "San Diego",
            "@id": "60121547",
            "affilname": "Department of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60121547",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Durham",
            "@id": "60113147",
            "affilname": "Duke University Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60113147",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Amherst",
            "@id": "60082605",
            "affilname": "Frontier Science &amp; Technology Research Foundation, Inc.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60082605",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Silver Spring",
            "@id": "60082111",
            "affilname": "Social &amp; Scientific Systems, Inc.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60082111",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Johannesburg",
            "@id": "60079992",
            "affilname": "University of the Witwatersrand Faculty of Health Sciences",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60079992",
            "affiliation-country": "South Africa"
        },
        {
            "affiliation-city": "Kampala",
            "@id": "60071691",
            "affilname": "Joint Clinical Research Center Uganda",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071691",
            "affiliation-country": "Uganda"
        },
        {
            "affiliation-city": "San Juan",
            "@id": "60071504",
            "affilname": "University of Puerto Rico School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071504",
            "affiliation-country": "Puerto Rico"
        },
        {
            "affiliation-city": "Tubarao",
            "@id": "60069644",
            "affilname": "Hospital Nossa Senhora da Conceicao",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60069644",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Boston",
            "@id": "60032499",
            "affilname": "Harvard T.H. Chan School of Public Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032499",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Boston",
            "@id": "60029929",
            "affilname": "Massachusetts General Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029929",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Aurora",
            "@id": "60028421",
            "affilname": "University of Colorado School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028421",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Rio de Janeiro",
            "@id": "60023997",
            "affilname": "Instituto Nacional de Infectologia Evandro Chagas (INI)",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023997",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Philadelphia",
            "@id": "60023009",
            "affilname": "Penn Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023009",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bethesda",
            "@id": "60017336",
            "affilname": "National Institute of Allergy and Infectious Diseases (NIAID)",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017336",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Boston",
            "@id": "60003526",
            "affilname": "Boston Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60003526",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Foster City",
            "@id": "60002909",
            "affilname": "Gilead Sciences Incorporated",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002909",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Stellenbosch",
            "@id": "60001565",
            "affilname": "Stellenbosch University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60001565",
            "affiliation-country": "South Africa"
        },
        {
            "affiliation-city": "Baltimore",
            "@id": "60001117",
            "affilname": "Johns Hopkins School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60001117",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60000881",
            "affilname": "Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Cleveland",
            "@id": "60000305",
            "affilname": "Case Western Reserve University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000305",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "Citius Pharmaceuticals",
        "Leonard Meron Bioscience",
        "Massachusetts Executive Office of Energy and Environmental Affairs",
        "Massachusetts Interscholastic Athletic Association",
        "Teradyne Inc",
        "National Institutes of Health",
        "National Institute of Allergy and Infectious Diseases",
        "Pfizer",
        "Gilead Sciences",
        "ACTG"
    ]
}